IL133637A0 - Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 - Google Patents
Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4Info
- Publication number
- IL133637A0 IL133637A0 IL13363798A IL13363798A IL133637A0 IL 133637 A0 IL133637 A0 IL 133637A0 IL 13363798 A IL13363798 A IL 13363798A IL 13363798 A IL13363798 A IL 13363798A IL 133637 A0 IL133637 A0 IL 133637A0
- Authority
- IL
- Israel
- Prior art keywords
- sulfonylated
- vla
- leukocyte adhesion
- adhesion mediated
- inhibit leukocyte
- Prior art date
Links
- 108010016626 Dipeptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000023404 leukocyte cell-cell adhesion Effects 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90442397A | 1997-07-31 | 1997-07-31 | |
| PCT/US1998/016070 WO1999006437A1 (en) | 1997-07-31 | 1998-07-31 | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL133637A0 true IL133637A0 (en) | 2001-04-30 |
Family
ID=25419137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13363798A IL133637A0 (en) | 1997-07-31 | 1998-07-31 | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0994896A1 (pt) |
| JP (1) | JP2001512139A (pt) |
| KR (1) | KR20010022405A (pt) |
| CN (1) | CN1265672A (pt) |
| AU (1) | AU8823498A (pt) |
| BR (1) | BR9811594A (pt) |
| CA (1) | CA2290748A1 (pt) |
| HU (1) | HUP0003921A3 (pt) |
| IL (1) | IL133637A0 (pt) |
| NO (1) | NO20000452L (pt) |
| PL (1) | PL338457A1 (pt) |
| WO (1) | WO1999006437A1 (pt) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| WO1998054207A1 (en) * | 1997-05-30 | 1998-12-03 | Celltech Therapeutics Limited | Anti-inflammatory tyrosine derivatives |
| ATE249421T1 (de) | 1997-06-23 | 2003-09-15 | Tanabe Seiyaku Co | Inhibitoren der alpha4-beta1 vermittelten zelladhäsion |
| US6645939B1 (en) | 1997-11-24 | 2003-11-11 | Merck & Co., Inc. | Substituted β-alanine derivatives as cell adhesion inhibitors |
| JP2001524465A (ja) * | 1997-11-24 | 2001-12-04 | メルク エンド カムパニー インコーポレーテッド | 細胞接着阻害剤としての置換β−アラニン誘導体 |
| US6197794B1 (en) * | 1998-01-08 | 2001-03-06 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| JP2002504534A (ja) | 1998-02-26 | 2002-02-12 | セルテック・セラピューティクス・リミテッド | α４インテグリンの阻害剤としてのフェニルアラニン誘導体 |
| US6521626B1 (en) * | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9811969D0 (en) * | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| US6685617B1 (en) | 1998-06-23 | 2004-02-03 | Pharmacia & Upjohn Company | Inhibitors of α4β1 mediated cell adhesion |
| GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
| US6333340B1 (en) * | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
| US6339101B1 (en) * | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
| US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
| GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
| CN1213025C (zh) * | 1999-02-18 | 2005-08-03 | 霍夫曼-拉罗奇有限公司 | 硫代酰胺衍生物 |
| US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
| WO2001012186A1 (en) * | 1999-08-13 | 2001-02-22 | Biogen, Inc. | Cell adhesion inhibitors |
| US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
| US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
| IL149758A0 (en) | 1999-12-28 | 2002-11-10 | Pfizer Prod Inc | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| WO2001068586A2 (en) * | 2000-03-14 | 2001-09-20 | Novartis Ag | α4β1 AND α4β7 INTEGRIN INHIBITORS |
| EP1332132B1 (en) | 2000-04-17 | 2007-10-10 | UCB Pharma, S.A. | Enamine derivatives as cell adhesion molecules |
| US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
| US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
| JP2004502762A (ja) | 2000-07-07 | 2004-01-29 | セルテック アール アンド ディ リミテッド | 二環性ヘテロ芳香環を含有するインテグリンアンタゴニストとしてのスクエア酸誘導体 |
| JP2004505110A (ja) | 2000-08-02 | 2004-02-19 | セルテック アール アンド ディ リミテッド | ３位置換イソキノリン−１−イル誘導体 |
| CA2420040C (en) | 2000-08-18 | 2009-02-03 | Ajinomoto Co., Inc. | New phenylalanine derivatives |
| US7199102B2 (en) | 2000-08-24 | 2007-04-03 | The Regents Of The University Of California | Orally administered peptides synergize statin activity |
| MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
| US6607735B2 (en) | 2000-12-21 | 2003-08-19 | Johnson & Johnson Consumer Companies, Inc. | Method for reducing the appearance of dark circles under the eyes |
| US6559174B2 (en) | 2001-03-20 | 2003-05-06 | Merck & Co., Inc. | N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| JP2004526733A (ja) | 2001-03-20 | 2004-09-02 | メルク エンド カムパニー インコーポレーテッド | 強力な細胞接着阻害剤としての置換ｎ−アリールスルホニル−プロリン誘導体 |
| US6855708B2 (en) | 2001-03-20 | 2005-02-15 | Merck & Co., Inc. | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| ATE464299T1 (de) * | 2002-02-20 | 2010-04-15 | Ajinomoto Kk | Neues phenylalaninderivat |
| WO2004066931A2 (en) * | 2003-01-24 | 2004-08-12 | Elan Pharmaceuticals Inc. | Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| WO2005000244A2 (en) * | 2003-06-25 | 2005-01-06 | Elan Pharmaceuticals, Inc. | Methods and compositions for treating rheumatoid arthritis |
| WO2005046697A1 (ja) * | 2003-11-14 | 2005-05-26 | Ajinomoto Co., Inc. | フェニルアラニン誘導体の徐放性経口投与製剤 |
| CN101664411A (zh) | 2003-11-14 | 2010-03-10 | 味之素株式会社 | 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂 |
| MX2007006750A (es) | 2004-12-06 | 2007-11-23 | Univ California | Metodos para mejorar la estructura y funcion de arteriolas. |
| CA2882445A1 (en) * | 2005-12-14 | 2007-06-21 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| WO2008103378A2 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
| NZ589086A (en) | 2008-04-11 | 2012-09-28 | Merrimack Pharmaceuticals Inc | Human serum albumin (HSA) linkers and conjugates thereof |
| EP2713722B1 (en) | 2011-05-31 | 2017-03-15 | Receptos, LLC | Novel glp-1 receptor stabilizers and modulators |
| MX365923B (es) * | 2011-12-12 | 2019-06-20 | Celgene Int Ii Sarl | Derivados de acido carboxilico que comprenden cuatro ciclos, que actuan como moduladores del receptor del peptido 1 similar al glucagon (glp-1) para terapia de enfermedades como la diabetes. |
| WO2014201172A1 (en) * | 2013-06-11 | 2014-12-18 | Receptos, Inc. | Novel glp-1 receptor modulators |
| KR102564946B1 (ko) * | 2014-07-25 | 2023-08-08 | 리셉토스 엘엘씨 | 신규 glp-1 수용체 조절제 |
| WO2016094729A1 (en) | 2014-12-10 | 2016-06-16 | Celgene International Ii Sarl | Glp-1 receptor modulators |
| US10308677B2 (en) * | 2014-12-19 | 2019-06-04 | Cem Corporation | Coupling method for peptide synthesis at elevated temperatures |
| US9969769B2 (en) | 2014-12-19 | 2018-05-15 | Cem Corporation | Coupling method for peptide synthesis at elevated temperatures |
| EP3873897B1 (en) | 2018-10-30 | 2024-08-14 | Gilead Sciences, Inc. | N-benzoyl-phenylalanine derivatives as alpha4beta7 integrin inhibitors for treating inflammatory diseases |
| PL3873900T3 (pl) | 2018-10-30 | 2025-06-02 | Gilead Sciences, Inc. | Imidazo[1,2-a]pirydynowe pochodne jako inhibitory integryny alpha4beta7 do leczenia chorób zapalnych |
| LT3873884T (lt) | 2018-10-30 | 2025-03-10 | Gilead Sciences, Inc. | 3-(chinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidin-2,4-diono dariniai kaip alfa4beta7 integrino inhibitoriai, skirti uždegiminių ligų gydymui |
| KR102659859B1 (ko) | 2018-10-30 | 2024-04-25 | 길리애드 사이언시즈, 인코포레이티드 | 알파4β7 인테그린의 억제를 위한 화합물 |
| EP4013499A1 (en) | 2019-08-14 | 2022-06-22 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2679903B1 (fr) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
| JPH04154732A (ja) * | 1990-10-18 | 1992-05-27 | Nippon Kayaku Co Ltd | 光学分割法 |
| WO1994007815A2 (en) * | 1992-09-25 | 1994-04-14 | Abbott Laboratories | Small peptide anaphylatoxin receptor ligands |
| AU675689B2 (en) * | 1992-12-01 | 1997-02-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| AU693143B2 (en) * | 1993-12-06 | 1998-06-25 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| JPH0873422A (ja) * | 1994-09-07 | 1996-03-19 | Kdk Corp | 新規アミノ酸エステルおよび白血球、エステラーゼ又はプロテアーゼの検出方法 |
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
-
1998
- 1998-07-31 JP JP2000505192A patent/JP2001512139A/ja not_active Withdrawn
- 1998-07-31 CA CA002290748A patent/CA2290748A1/en not_active Abandoned
- 1998-07-31 KR KR1020007000985A patent/KR20010022405A/ko not_active Withdrawn
- 1998-07-31 PL PL98338457A patent/PL338457A1/xx not_active Application Discontinuation
- 1998-07-31 HU HU0003921A patent/HUP0003921A3/hu unknown
- 1998-07-31 EP EP98939871A patent/EP0994896A1/en not_active Withdrawn
- 1998-07-31 IL IL13363798A patent/IL133637A0/xx unknown
- 1998-07-31 CN CN98807721A patent/CN1265672A/zh active Pending
- 1998-07-31 AU AU88234/98A patent/AU8823498A/en not_active Abandoned
- 1998-07-31 BR BR9811594-4A patent/BR9811594A/pt not_active IP Right Cessation
- 1998-07-31 WO PCT/US1998/016070 patent/WO1999006437A1/en not_active Ceased
-
2000
- 2000-01-28 NO NO20000452A patent/NO20000452L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20000452L (no) | 2000-03-27 |
| EP0994896A1 (en) | 2000-04-26 |
| CN1265672A (zh) | 2000-09-06 |
| NO20000452D0 (no) | 2000-01-28 |
| CA2290748A1 (en) | 1999-02-11 |
| PL338457A1 (en) | 2000-11-06 |
| JP2001512139A (ja) | 2001-08-21 |
| AU8823498A (en) | 1999-02-22 |
| HUP0003921A3 (en) | 2001-03-28 |
| KR20010022405A (ko) | 2001-03-15 |
| WO1999006437A1 (en) | 1999-02-11 |
| BR9811594A (pt) | 2000-09-05 |
| HUP0003921A2 (hu) | 2001-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL133637A0 (en) | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HUP0002682A3 (en) | Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| IL133641A0 (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| IL133640A0 (en) | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HUP0002680A3 (en) | Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| IL133636A0 (en) | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| IL133638A0 (en) | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| IL133639A0 (en) | Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| AU2623900A (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| AU5489099A (en) | Seed-preferred promoters | |
| AU5732298A (en) | Plant expansin promoter sequences | |
| GB9720922D0 (en) | Adhesives | |
| AU3348800A (en) | Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| AU3348700A (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HK1026434A (en) | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HK1025976A (en) | Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HK1026218A (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HK1026435A (en) | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HK1026219A (en) | Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| ZA986830B (en) | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4. | |
| HK1026216A (en) | Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HK1026424A (en) | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| HK1026217A (en) | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| GB9706377D0 (en) | Novel compound | |
| GB9716081D0 (en) | Adhesives |